Target intelligence / Profile preview

Reactive oxygen and nitrogen species and electrophilic oxidants (ROS/RNS)

Target
ROS/RNS
Molecular classification
Reactive chemical species, Free radicals, Non-radical oxidants, Electrophiles
01

Overview

Reactive oxygen and nitrogen species (ROS/RNS) and electrophilic oxidants are a diverse group of highly reactive molecules, including free radicals like superoxide and hydroxyl radicals, as well as non-radicals like hydrogen peroxide and peroxynitrite (PMID: 28249118). In physiological conditions, they serve as critical secondary messengers in redox signaling pathways, regulating processes such as cell proliferation, differentiation, and the immune response (PMID: 30546634). However, an imbalance between their production and the body's antioxidant defenses leads to oxidative and nitrosative stress, causing damage to lipids, proteins, and DNA (PMID: 23626330). This damage is a hallmark of numerous pathologies, including cancer, cardiovascular diseases, and neurodegeneration (PMID: 25979354). Therapeutic strategies often involve the use of small-molecule scavengers like Edaravone or the induction of endogenous antioxidant enzymes to neutralize these species (PMID: 28838208). Despite their potential, targeting these species is challenging due to their transient nature and their dual role in both health and disease (PMID: 24591372).

Other names
Reactive oxygen speciesReactive nitrogen speciesElectrophilic speciesOxidantsFree radicalsPro-oxidantsReactive oxygen and nitrogen species
02

Mechanism of action

Direct scavenging of free radicals, neutralization of electrophilic groups, and induction of endogenous antioxidant defense systems via pathways such as Nrf2-KEAP1.

03

Biological functions

Redox signalingImmune responseCell proliferationApoptosisHomeostasisProtein modificationGene expression regulation
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseIschemia-reperfusion injuryAgingDiabetes mellitus
05

Safety considerations

Interference with essential physiological redox signalingAntioxidant paradox (potential to increase mortality at high doses)Lack of tissue specificityPotential to promote survival of established cancer cells
06

Interacting drugs

N-acetylcysteine

8 more in the full profile.

07

Biomarkers

8-hydroxy-2-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)Protein carbonyls3-NitrotyrosineF2-isoprostanesGlutathione/Glutathione disulfide (GSH/GSSG) ratio

Beyond the preview

Go deeper on Reactive oxygen and nitrogen species and electrophilic oxidants (ROS/RNS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen and nitrogen species and electrophilic oxidants (ROS/RNS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call